- Home
- Equipment
- north america
- clinical program
Refine by
Clinical Program Equipment Supplied In North America
47 equipment items found
Manufactured by:Elicio Therapeutics based inBoston, MASSACHUSETTS (USA)
Our lymph node-targeted mKRAS cancer vaccine; Our Amphiphile (AMP)-powered lead candidate, ELI-002, generates a robust immune response against mutant Kristen rat sarcoma (mKRAS), with the potential to offer patients a stronger fight against the most aggressive cancers. Preliminary data have shown that ELI-002 produces a potent mKRAS-specific T-cell response, including both CD4+ and CD8+ ...
Manufactured by:AOBiome Therapeutic, LLC based inCambridge, MASSACHUSETTS (USA)
We have completed six Phase 2 clinical programs and multiple pre-clinical programs. Over 1,000 patients have been enrolled in our clinical trials since 2016. All of those patients except for 28 in our open label pediatric study have been enrolled in randomized double-blind placebo controlled ...
Manufactured by:BioXcel Therapeutics, Inc. based inNew Haven, CONNECTICUT (USA)
BXCL501 is our most advanced neuroscience clinical program. BXCL501 is a proprietary, sublingual film formulation of dexmedetomidine, a selective alpha-2 receptor agonist. It is being investigated for at-home use for the acute treatment of agitation in bipolar and schizophrenia patients, for agitation in Alzheimer’s disease, and as an adjunctive treatment ...
Manufactured by:Elixir Medical Corporation based inMilpitas, CALIFORNIA (USA)
Sirolimus is the most widely known mTOR inhibitor with a well-established safety and effectiveness profile in various treatment applications: Drug-eluting stents, Transplant, Oncology. Novolimus and Sirolimus have been studied as part of Elixir Medical’s Clinical Programs. These clinical trials for DynamX™, DESyne®, ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
CT-132 is under development as a clinically-validated digital program for ...
by:Oligomerix, Inc. based inWhite Plains, NEW YORK (USA)
While Alzheimer’s is the largest tauopathy, other tauopathies are rare diseases that present accelerated regulatory pathways and significant near-term commercial opportunities. These rare diseases shown in Chart A below have a tau etiology similar to AD. Oligomerix’s 1st clinical program focuses on demonstrating safety and efficacy of our lead ...
Manufactured by:MD Spiro, A MicroDirect Company based inLewiston, MAINE (USA)
The CO Check+ is an innovative smoking cessation tool designed specifically for use in smoking cessation programs and clinics. One single breath of expiration into the CO Check+ provides instant results in PPM and %COHb via the large, easy-to-read ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Clickheart is under development as a clinically-validated digital program for acute coronary ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
CT-161 is under development as a clinically-validated digital program for overactive ...
Manufactured by:Microbion Corporation based inBozeman, MONTANA (USA)
Microbion has two Phase 2 clinical programs in diabetic foot ulcer infection and orthopedic implant infection. In addition, preclinical programs are under development for multiple therapeutic indications, including the treatment of serious respiratory ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Clickadian is under development as a clinically-validated fully digital program for ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso1 is a clinical stage development program aiming at harnessing the potential of Christensenella minuta as a groundbreaking biotherapy to treating obesity and metabolic disorders. The goal of our disruptive approach is to return to obese patients christensenella, which have the unique ability to repair the unbalanced microbiome, thereby restoring impaired key ...
Manufactured by:OraSure Technologies based inBethlehem, PENNSYLVANIA (USA)
With a fast and easy-to-administer collection process, Intercept is ideal for workplace, criminal justice, drug treatment centers, and clinical setting screening programs, among ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
GRAIL is poised to detect cancer early by combining high-intensity sequencing of unprecedented breadth and depth with the techniques of modern data science. Through what we believe to be one of the largest clinical study programs ever pursued in genomic medicine, GRAIL is creating vast datasets to develop evidence supporting our ...
Manufactured by:Premier Biotech, Inc. based inMinneapolis, MINNESOTA (USA)
Premier Biotech’s CLIA-Waived (Clinical Laboratory Improvement Amendments) multi-drug integrated cup and dip products offer the ability to test for 5-14 drugs. CLIA-Waived test products are cleared by the FDA for over-the-counter (OTC) use, suited for workplace and clinical drug testing programs and approved for waiver under the CLIA ...
Manufactured by:Catalent, Inc based inSomerset, NEW JERSEY (USA)
Antibody-drug conjugates (ADCs) combine the targeted binding specificity and pharmacological advantages of monoclonal antibodies with the potency advantages of small molecule chemotherapy agents via conjugation with chemical linkers. With 10 approved products and a large and growing list of programs in clinical and pre-clinical development, ADCs ...
Manufactured by:Engenious Design based inPrairie Village, KANSAS (USA)
Engenious helps medical device companies apply the latest technology in medical diagnostic and therapeutic devices. Our clinical insights program provides a clearer vision of the current and emerging needs of clinicians (the ultimate end user!). Feedback from professionals gives us the opportunity to design and develop the next innovations in medical devices and ...
by:Align Technology, Inc. based inTempe, ARIZONA (USA)
The Invisalign system is the most advanced clear aligner system in the world. Backed by two decades of innovation, the Invisalign system has helped bring smiles to over 9.6 million people including over 2.4 million ...
Manufactured by:Cabaletta Bio, Inc. based inPhiladelphia, PENNSYLVANIA (USA)
DSG3/1-CAART is designed to selectively target and kill the B cells that express the pathogenic autoantibodies while preserving the healthy B cells critical to immune function. We anticipate that much of what we learn from our DSG3-CAART program, including clinical trial design in the DesCAARTesTM trial, will inform and potentially accelerate the development of ...
Manufactured by:Omni-Biotic based inPort Chester, NEW YORK (USA)
This 3-month OMNi-BiOTiC® probiotic program is designed to reset the gut microbiome and support overall wellness. Based on over 30 years of gut microbiome research and 100+ clinical studies, this program is curated by the Founder of Omni-Biotic and CEO of the globally recognized microbiome science center Institut Allergosan, Anita ...